Cutaneous T-cell lymphoma (CTCL) - vorinostat - initial authority application form (PB216)

Use this form to apply for initial PBS-subsidised treatment with vorinostat for cutaneous T-cell lymphoma.

Page last updated: 17 June 2024.
QC 37761